Noul Co.,Ltd. (KOSDAQ: 376930)

Market Cap	84.79B
Revenue (ttm)	2.27B
Net Income (ttm)	-20.19B
Shares Out	36.95M
EPS (ttm)	-544.16
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,667,254
Open	2,270.00
Previous Close	2,280.00
Day's Range	2,150.00 - 2,465.00
52-Week Range	1,820.00 - 6,660.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 11, 2024

About Noul Co.,Ltd.

Noul Co.,Ltd. engages in the in vitro diagnosis and remote diagnosis business worldwide. It offers miLab, an AI-based blood diagnostic medical device that automates sample preparation, imaging, and analysis. The company also provides malaria diagnostics, blood cell morphology analysis, cancer morphology, and immunohistochemistry services. Noul Co.,Ltd. was founded in 2015 and is headquartered in Yongin-si, South Korea.

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2015
• Employees: 139
• Stock Exchange: KOSDAQ
• Ticker Symbol: 376930

Financial Performance

In 2023, Noul Co.,Ltd.'s revenue was 2.73 billion, an increase of 404.51% compared to the previous year's 541.88 million. Losses were -16.32 billion, 19.3% more than in 2022.